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IN 1917, at a time when the existence ofthe various hormones ofthe pituitary
was not established and none had been isolated, one of us (C. F.) advanced a
working hypothesis on the relationship of this gland and neoplastic disease. The
necessity for further research into the effect ofthe pituitary gland (anterior lobe)
on cancer was pointed out. At the time it was known that adenomas of this
gland produced abnormalities in children and young adults; it was therefore
postulated that in later life, when gigantism and acromegaly were no longer
possible, increased activity of the pituitary gland might be responsible for the
production of tumours (Funk, 1917). For a long time and for obvious reasons
it was impossible to put this hypothesis to a test. Thanks to the classical work
of Evans, Li and Simpson (1948) we now have the necessary tools for prelimin-
ary and systematic appraisal of the importance of various hormones of the
anterior pituitary in tumour growth.
The purpose of the work reported in this paper was to test the effect of
various anterior pituitary and related hormones upon the growth of implanted
tumours in hypophysectomized rats. As a supplement to this work we also
dealt with the removal of certain organs (mainly glands of internal secretion)
on the rate ofgrowth of a transplanted rat tumour in otherwise intact animals.
While there is no doubt that studies on this subject have already been made,
it appears doubtful whether a systematic study was ever made of the effect of
the removal of these organs upon the growth of one particular tumour. As an
addendum we have also investigated the influence of alloxan diabetes upon the
tumour.
MATERIALS AND METHODS.
Hypophysectomy experiments.
The hypophysectomized and normal rats, Sprague-Dawley strain, were
supplied to us via air freight by the Hormone Assay Laboratories, Inc., Chicago,
Illinois. The tumour used was the Walker Carcinosarcoma 256. As a criterion
of completeness ofhypophysectomy we have used the test established by Cortis-
Jones, Crooke, Henley, Morris and Morris (1950), and have eliminated from
our experiments those rats not receiving gonadotropin whose testes weighed
over 500 mg. In order to ascertain the relative purities of the hormones used in
this investigation the following organs were excised and weighed: the thyroids,
the adrenals, the testes and thespleen.
The animals were divided into groups after tumour implantation, whichEFFECT OF HORMONAL FACTORS ON TRANSPLANTED RAT TUMOUR 281
usually was made 3 days after hypophysectomy. They were weighed twice
weekly and their growth curves noted. The injections of hormones were made
subcutaneously 5 times a week, in some cases twice daily. The diet consisted of
Purina Laboratory Chow, enriched with whole milk (powdered), whole wheat
bread and canned dog food ad libitum. Sucrose 1 per cent was added to the
drinking water.
Experiment I.-Hypophysectomized rats were divided into 3 groups: Group
H received no treatment; Group SG received a total of 3.8 mg. (19.5 I.U.) of
pregnant mare serum gonadotropin (our own preparation); Group GH received
a total of 9.36 mg. (13.0 R.G.U.) of growth hormone. Intact animals were used
as a control group. The animals were sacrificed on the thirteenth day after
tumnour implantation.
Experiment II.-Hypophysectomized rats were divided into 4 groups: Group
H, controls; Group GH received the same growth hormone as in Experiment I-
12.0 mg. (16.7 R.G.U.); Group T received 3.0 mg. (30 J-S U.) of thyrotropic
hormone; Group ACTH received 8.0 mg. of adrenocorticotropic hormone; The
animals were sacrificed 12 days after tumour implantation.
Experiment III.-Hypophysectomized rats were divided into 3 groups:
Group H, controls; Group FSH received a total of 2-5 mg. (116 A.U.) of sheep
follicle stimulating hormone; Group ACTH, a total dose of 13.0 mg. in 2 daily
injections of ACTH. The animals were sacrificed 14 days after tumour
implantation.
Experiment IV.-Hypophysectomized rats were divided into 2 groups: Group
H, controls; Group LH received a total dose of 15.0 mg. of lactogenic hormone.
The animals were sacrificed 15 days after tumour implantat on.
At the time the animals were sacrificed the tumours were excised carefully
and weighed immediately. All of the anterior pituitary hormones used were
specifically active, as shown by the response of the endocrine glands undertheir
control. The thyrotropic hormone showed evidence of possible gonadotropic
impurity, while the ACTH used in Experiment III showed evidence of possible
growth hormone impurity.
The results of these experiments are summarized in Table II.
Surgical removal experiments.
The same tumour was used here. In all we have performed 15 experiments,
removing the testes, ovaries, thyroids (with parathyroids), adrenals and spleen.
We did not perform any pancreatectomies, but we did use alloxan to destroy the
function of the pancreas, which is responsible for insulin production. In our sur-
gical procedures we have followed the recommendations of Farris and Griffith
(1949). To check on the completeness of the surgical procedures used we have
excised and weighed, at the time of sacrifice, those organs that are in a physio-
logical relationship to the excised gland. For instance, in orchidectomy the
seminal vesicles and the prostate were weighed. At the same time the site of
the operation was carefully scrutinized for any remnant of the gland, or any
sign of regeneration of the excised organ. Where such was present, the animal
was eliminated from the experiment. The diet was the same as in the hypo-
physectomy experiments. All animals received tap water, except the adrena-
lectomized animals, which received 1 per cent saline. In some experiments rats
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ofdifferent age groups were used to study the effect ofsexualmaturity. Inothers
the effect of the time between the operation and the tumour implant was
also studied. In our splenectomy experiments various rat strains were used in
an endeavour to find a strain less susceptible to Bartonella muris infection.
Details of the experimental procedure are summarized in Table I, the results
obtained in Table III.
TABLE I.
No. of
Strain. . rats Treatment. Sex. Strain. rats used.
Orchidectomy:
Exp. I
Exp. II
Exp. III
Exp. IV
. Wistar
. Sherman
,,
12
30
22
23
Average
weight at
operation
(g.).
. 190-200
80-90
80-90
45-50
Days after
operation
implant made.
2
7
3
13
Days after
implant
sacrificed.
15
14
13
13
Ovariectomy:
Exp. V
Exp. VI
Exp. VII
Thyroidectomy:
Exp. VIII .
Exp. IX
Adrenalectomy:
Exp. X, XI .
Splenectomy:
Exp. XII .
Exp. XIII .
Alloxan diabetes:
Exp. XIV .
Exp. XV .
Notes:
M
M
M
M
M
. 602 . 80-90 .
. Wistar . 223 . 140-150 . ·,, . 254 . 95-105 .
. Sherman . 285 . 130-140 .
,, . 286 . 130-150 .
1 12
1 15
13
1
13
13
1 Of the controls 40 per cent had open vaginas, none of the castrates, at time of implant.
a Mortality was about 30 per cent of the animals operated upon.
8 Mortality of 33 per cent of the operated animals, probably due to Bartonella muria infection.
4 All animals received 60 mg. chloromycetin before splenectomy. Later 20 mg. of the anti.
biotic. No improvement in survival was noted.
s Pre-implant group received a total of 80 mg. of alloxon-monohydrate before tumour im-
plantation (one dayafter adose of 30mg. the animals showed aglycosuria; tumourimplantation was
made that day); post-implant received a total dose of 90 mg. of alloxan from the time of tumour
implantation to the end of the experiment. Shaefer-Hartman blood-sugar determinations were as
follows: Pre-implant 461-9 mg. per cent; post-implant 57-2 mg. per cent; controls 77-8 mg. per
cent.
6 Same conditions as in Experiment XIV were used.
F
F
F
18
21'
17
16
30
4
19
5
M
M
50-60 .
. 30-40 .
. 100-120 .
. 130-150 .
80-90 .
15
13
11
. Wistar .
. Sherman.
3
4
15
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Average body
Group No. of weight at rats. implant
(g.).
Exp. I.
H
SG
GH
Intact
Exp. II.
H
GH
T
ACTH
Exp. III.
H
FSH
ACTH
Exp. IV.
9
10
9
9
11
8
11
11
18
14
14
87.6
88.0
88.2
103.6
87-3
82-6
·815
87.2
84.2
89.1
87 1
TABLE II.
Average change
body weight
(%).
. -07
+3'4
+26'5
+61 5
+3.8
+32.5
+10.5
+3.5
-6-4
-1.5
+11.8
Median tumour
weight
(g.).
1*31
1*75
3*87
8*35
2-72
5.35
4*07
4'13
1'73
2 28
4.89
H . 11 . 87.1 . +77 . 245 . ..
LH . 9 . 881 . +12.5 . 3.26 . 188
* Ratio is the mg. tumour difference from hypophysectomized control tumour weight per g.
body-weight gain difference from hypophysectomized control gain.
TABLE III.
Group.
Orchidectomy:
Exp. I.
Castrates
Controls .
Average body
No. of weight at
rats. implant
(g.).
6
6
191 -2
214.0
Average change
body weight
(%).
Median
tumour
weight
(g.).
+27,8 . 10.01
+23.2 . 8-71
Exp. II.
Castrates
Cast.+Testost..
Controls .
. 10
12
107*8
110.*0
. 13 . 92.0
. 10 . 91.0
+43.6
+50-8
+49.0
+41.3
4*88 . 107
4*20 . 126
7.43 . 165
5. 59 . 148
Ratio.*
122
107
110
112
260
over 1000
137
202
Ratio.*
. 158
145
* 10
. 10
. 10
101.2
97-0
95*0
+37.0
+28 3
+45.7
Exp. III.
Castrates
Controls .
Exp. IV.
Castrates
Controls .
19I
3*12
3*60
3-70
83
131
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TABLE III--(cont.).
Group.
Ovariectomy:
Exp. V.
Castrates
Controls .
Average body
No. of weight at
rats. implant
(g.).
'. 11
. 7
Exp. VI.
Castrates
Controls .
. 12
9
70 5
77 6
85 7
84.1
Average change
body weight
(%).
+35 2
+24 6
+44.2
+30.9
Exp. VII.
Castrates
Controls.
Thyroidectomy:
Exp. VIII.
Thyroidectomized
Controls .
8
8
135.5
151 4
+20.6
. +44-0
270 . 181
9.26 . 151
Exp. IX.
Thyroidectomized
Thyroidect. +
thyroxine
Controls .
. 11 . 95.0
. 10
. 9
97 .3
109·1
+23.6
-0.9
+42.4
2. 84 . 124
319 ·5.35 115 115
Adrenalectomy:
Exp. X.
Adrenalectomized
Controls .
Exp. XI.
Adrenalectomized
Controls .
Splenectomy:
Exp. XII.
Splenectomized
Controls
Exp. XIII.
Splenectomized
Controls .
. 12
. 10
5
9
8
. 10
9
10
80.4
86 8
83 8
80'1
130 6
140 2
119'4
131'1
+32.4
+54.1
+29 6
+50:0
1.42
4.72
092
2.40
77
101
44
60
+31-8 . 13.83 . 270
· +36-4 . 9'23 . 180
+30 -0
+23-0
627 . 182
5'20 . 169
Median
tumour
weight
(g.).
1.33
3.57
616
6.13
Ratio.*
53
188
. 163
236
9
8
117 6
121.5
+33-7
+28.9
2-15
4-45
62
106
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TABLE III-(ont.).
Average body Average change tumour
Group. No. of weight at body weight
ur Ratio. rats. implant bd weight
(g.). (g.). Alloxan diabetes:
Exp. XIV.
Pre-implant . . 8 . 162.4 . +11.2 . 118 .
Post-implant . . 10 . 179.9 . +15.2 . 420 . 153
Controls . . . 10 . 169.9 . +22.2 . 4*44 . 117
Exp. XV.
Pre-implant . . 9 . 120.0 . +14.2 . 2.07 . 122
Post-implant . . 9 . 1610 . +21.1 . 4.28 . 126
Controls . . . 10 . 150.0 . +25 2 . 8.01 . 212
* Ratio is mg. tumour weight per g. body-weight gain.
DISCUSSION.
Ball and Samuels (1938) have shown that the growth of tumours implanted
into hypophysectomized rats is greatly reduced in rate, but that a progressive
development ofmalignant tissue continues. Recentlythe authors (Funk, Ehrlich,
Tomashefsky and Soukup, 1950a; Funk, Tomashefsky, Ehrlich and Soukap,
1950b) have shown that in hypophysectomized rats the tumour grew to one-sixth
the size of the tumours in intact animals, and that the administration of certain
anterior pituitary extracts partially counteracted the effect of hypophysectomy
on the tumours. In the same paper we were able to show that an enriched diet
was able to restore, in a small way, the growth ofthe tumour. Usingtheenriched
diet in our present work, we have attempted to restore tumour size by the
administration of some anterior pituitary hormones and serum gonadotropin.
Growth hormone increased tumour weight of hypophysectomized animals so
treated. However, this increase is directly proportional to the increase in body
weight due to the hormone. Thus, tumour weight difference per g. body weight
difference is the same for both growth hormone treated and intact animals
using untreated hypophysectomized animals as the base. It would appear that
the influence of growth hormone on tumour growth is related to its effect upon
the general metabolic condition of the animal.
This is not true for ACTH and thyrotropic hormone. These two hormones
cause a greater increase in tumour growth than could be expected from their
effect upon body growth, using the same criterion. The ratio of tumour
weight to body weight gain in adrenalectomized animals seems to confirm the
fact that without adrenal hormones the tumour does not grow as well as in
intact rats. ThisistheoppositeoftheeffectofACTHtreatment. Therestorative
effect of the latter hormone and the decreasing effect of the operation, greater
than their respective actions upon body growth, show a clear effect on the tumour
itself. Our data are not as clear in the thyroidectomy experiments, however;
in one experiment the tumour-body weight ratio is indicative of the depressant
effect ofthis operation upon the tumour. In the other experiment the adminis-
tration of thyroxine to a thyroidectomized animal had the same effect as thyro-C. FUNK, P. TOMASHEFSKY, R. SOUKUP AND A. EHRLICH
tropic hormone given to a hypophysectomized animal. This effect was an
increase in tumour size greater than could be expected from the body growth.
The effect of FSH and serum gonadotropin on hypophysectomized animals
was not very marked either on absolute tumour weight or on tumour weight per
g. body weight gain. Lactogenic hormone may have some effect upon tumour
weight according to the second criterion. The removal of the gonads (male and
female) partially corroborated these findings. Orchidectomy had apparently little
effect upon tumour size, but ovariectomy produced a significant decrease in such
size per g. body-weight gain. The treatment ofcastrated males with testosterone
may have stimulated tumour growth.
Splenectomy may have had some effect upon increasing tumour size by both
criteria.
While it is clear that diabetes per se reduces tumour growth, it is not so clear
whether or not this reduction is related to body weight.
It has been shown by McEuen and Thomson (1933) that the reduced rate of
tumour growth in hypophysectomized animals could not be solely attributable
to the concomitant metabolic deficiency. In their studies on intact animals,
Evans, Moon, Simpson and Li (1950) have found that only by long-continued
treatment with growth hormone were they able to produce neoplasms, while
Shulman and Greenberg (1949) in a shorter experiment, using intact mice, found
no effect upon tumour growth with this hormone. We (Funk, Ehrlich, Toma-
shefsky and Soukup, 1950a) have been able to show, using tissue extracts, that
it is possible to increase the rate of tumour growth, the increase in tumour size
being accompanied by a greater loss in weight than is found in control animals.
It would appear, then, that the ability of the hormones found to restore
tumour growth, except possibly growth hormone, is not entirely due to their
influence upon the general metabolism of the animal, but may be due in part
to some effect upon the tumour itself. Since the hormones used were them-
selves only as pure as they can be made to-day, it may be possible that the
effect they may have had upon the tumour growth was not due to the hormones
per se, but, in fact, to an unknown substance common to them all. Further work
to test this is now being carried out.
SUMMARY.
Using the criterion of the ratio of tumour size to body-weight gain, it was
found that growth hormone, serum gonadotropin and follicle stimulating hormone
had very little effect upon the growth of implanted tumours in hypophysec-
tomized rats. Adrenocorticotropic hormone, thyrotropic hormone and lacto-
genic hormone seemed to stimulate tumour growth.
In otherwise intact animals, orchidectomy, splenectomy and thyroidectomy
had only slight effects, respectively, upon the tumour, using similar criteria.
Adrenalectomy and ovariectomy reduced tumour growth.
Alloxan diabetes reduced tumour growth per se, but it is not clear whether
this is a general metabolic effect.
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